Evaluation of the Impact of a Collaboration Between Hospital and Community Pharmacists at Hospital Discharge
Launched by PHARMACIE DES HOPITAUX DE L'EST LEMANIQUE · Mar 24, 2025
Trial Information
Current as of July 25, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how better teamwork between hospital pharmacists and community pharmacists can help patients who are going home after being hospitalized. When patients take many medications, their prescriptions can change during their hospital stay, which sometimes leads to mistakes when they go back to their regular pharmacy. The researchers want to find out if having a hospital pharmacist communicate important information directly with the community pharmacy can reduce these medication errors for adult patients who are taking seven or more medications.
To be eligible for the trial, participants should be adults aged 65 to 74 who have spent more than 48 hours in the internal medicine ward and are going home with seven or more prescribed drugs. They also need to be able to give consent, meaning they understand the study and agree to participate. If someone joins the study, their hospital will send necessary information to their usual pharmacy, but they won’t have to do anything extra besides visiting that pharmacy after discharge. The trial is not yet recruiting participants, but it aims to make the process of managing medications smoother and safer for patients after they leave the hospital.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients admitted to the internal medicine ward for more than 48 hours
- • Patients prescribed seven or more drugs at the time of screening
- • Patients discharged to home
- • Patients able to give informed consent as documented by signature
- Exclusion Criteria:
- • Patient discharged to another hospital, nursing home or rehabilitation clinic
- • Refusal of the community pharmacy to participate
- • Inability to sign consent and follow the procedures of the study, due to language problems, psychological disorders, dementia, alterations of consciousness and lack of judgement
About Pharmacie Des Hopitaux De L'est Lemanique
Pharmacie des Hôpitaux de l'Est Lémanique is a leading pharmaceutical organization dedicated to advancing healthcare through innovative clinical research and development. As a key sponsor of clinical trials, the organization focuses on enhancing therapeutic options and improving patient outcomes across various medical fields. With a commitment to rigorous scientific standards and ethical practices, Pharmacie des Hôpitaux de l'Est Lémanique collaborates with healthcare professionals and institutions to facilitate groundbreaking studies that contribute to the overall improvement of healthcare delivery and patient well-being.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rennaz, Vaud, Switzerland
Patients applied
Trial Officials
Anne-Laure Blanc, PharmD, PhD
Study Director
Pharmacie des Hôpitaux de l'Est Lémanique
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported